Found: 14
Select item for more details and to access through your institution.
In Vitro and In Vivo Pharmacological Comparison of Mu‐Opioid Receptor Activity of the Kratom (Mitragyna speciosa) Alkaloid Mitragynine and its Metabolite 7‐Hydroxymitragynine.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058605
- By:
- Publication type:
- Article
N‐Phenyl‐1,2,3,4‐tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β‐Hydroxysteroid Dehydrogenase 1 Inhibitors.
- Published in:
- ChemMedChem, 2021, v. 16, n. 1, p. 259, doi. 10.1002/cmdc.202000762
- By:
- Publication type:
- Article
Metabolism of Speciociliatine, an Overlooked Kratom Alkaloid for its Potential Pharmacological Effects.
- Published in:
- AAPS Journal, 2022, v. 24, n. 5, p. 1, doi. 10.1208/s12248-022-00736-8
- By:
- Publication type:
- Article
Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain.
- Published in:
- Molecules, 2022, v. 27, n. 11, p. 3617, doi. 10.3390/molecules27113617
- By:
- Publication type:
- Article
Mitragynine Reverses Paclitaxel Chemotherapy‐Induced Peripheral Neuropathy and is Mediated via Opioid Receptor Involvement.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.0R851
- By:
- Publication type:
- Article
Probing the Activity of Mitragyna Speciosa (Kratom) Alkaloids at Serotonin G Protein‐Coupled Receptors.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R2407
- By:
- Publication type:
- Article
Effects of Mitragynine and its Active Metabolites on the Reinforcing Effects of Remifentanil and Cocaine in Rats Self‐Administering Remifentanil.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R5776
- By:
- Publication type:
- Article
Serotonin 5‐HT<sub>1A</sub> Receptor Activity of Kratom Alkaloids Mitragynine, Paynantheine, and Speciogynine.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.04764
- By:
- Publication type:
- Article
Pharmacological Characterization of Mitragynine: Antinociception, Respiratory Depression, Self‐Administration, Drug Discrimination, Tolerance, and withdrawal in Rats.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.02725
- By:
- Publication type:
- Article
Mitragynine Attenuates the Development of Tolerance to and Withdrawal from Morphine in Rats.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.05506
- By:
- Publication type:
- Article
Assessment of Contribution of 7‐Hydroxymitragynine and Mitragynine Pseudoindoxyl to the MU‐Opioid Activity of Mitragynine.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.05475
- By:
- Publication type:
- Article
The Lofexidine‐Like Discriminative Effects of the Primary Kratom Alkaloid Mitragynine in Rats.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.04912
- By:
- Publication type:
- Article
Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells.
- Published in:
- Pathogens, 2021, v. 10, n. 11, p. 1514, doi. 10.3390/pathogens10111514
- By:
- Publication type:
- Article
Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00678
- By:
- Publication type:
- Article